These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


90 related items for PubMed ID: 15564798

  • 1. Distinct incidence patterns among in situ and invasive breast carcinomas,with possible etiologic implications.
    Anderson WF, Chu KC, Devesa SS.
    Breast Cancer Res Treat; 2004 Nov; 88(2):149-59. PubMed ID: 15564798
    [Abstract] [Full Text] [Related]

  • 2. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.
    Anderson WF, Chu KC, Chang S, Sherman ME.
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1128-35. PubMed ID: 15247123
    [Abstract] [Full Text] [Related]

  • 3. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
    Jemal A, Ward E, Thun MJ.
    Breast Cancer Res; 2007 Jul; 9(3):R28. PubMed ID: 17477859
    [Abstract] [Full Text] [Related]

  • 4. Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome.
    Anderson WF, Jatoi I, Devesa SS.
    Breast Cancer Res Treat; 2005 Mar; 90(2):127-37. PubMed ID: 15803359
    [Abstract] [Full Text] [Related]

  • 5. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
    Li CI, Daling JR, Malone KE.
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1008-11. PubMed ID: 15824180
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Is male breast cancer similar or different than female breast cancer?
    Anderson WF, Althuis MD, Brinton LA, Devesa SS.
    Breast Cancer Res Treat; 2004 Jan; 83(1):77-86. PubMed ID: 14997057
    [Abstract] [Full Text] [Related]

  • 8. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?
    Anderson WF, Chu KC, Chang S.
    J Clin Oncol; 2003 Jun 15; 21(12):2254-9. PubMed ID: 12805323
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of age distribution patterns for different histopathologic types of breast carcinoma.
    Anderson WF, Pfeiffer RM, Dores GM, Sherman ME.
    Cancer Epidemiol Biomarkers Prev; 2006 Oct 15; 15(10):1899-905. PubMed ID: 17035397
    [Abstract] [Full Text] [Related]

  • 11. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB, Feuer EJ, Harlan LC, Abrams J.
    J Natl Cancer Inst Monogr; 2006 Oct 15; (36):7-15. PubMed ID: 17032888
    [Abstract] [Full Text] [Related]

  • 12. Incidence and clinical features of breast cancer in the Auckland region.
    Newman PD, Mason BH, Holdaway IM, Kay RG, Arthur JF, Hitchcock GC.
    N Z Med J; 1992 Apr 08; 105(931):117-20. PubMed ID: 1313956
    [Abstract] [Full Text] [Related]

  • 13. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
    Ringberg A, Andersson I, Aspegren K, Linell F.
    Eur J Surg Oncol; 1991 Oct 08; 17(5):466-76. PubMed ID: 1657650
    [Abstract] [Full Text] [Related]

  • 14. Modelling the impact of detecting and treating ductal carcinoma in situ in a breast screening programme.
    McCann J, Treasure P, Duffy S.
    J Med Screen; 2004 Oct 08; 11(3):117-25. PubMed ID: 15333269
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL.
    APMIS Suppl; 2003 Oct 08; (108):1-67. PubMed ID: 12874968
    [Abstract] [Full Text] [Related]

  • 17. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA, Women's Health Initiative Investigators.
    J Natl Cancer Inst; 2007 Nov 21; 99(22):1695-705. PubMed ID: 18000216
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI, Malone KE, Saltzman BS, Daling JR.
    Cancer; 2006 May 15; 106(10):2104-12. PubMed ID: 16604564
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.